Pubmed ID |
Author |
Year |
Title |
19704410
|
Svendsen PF
|
2009
|
Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
|
19706563
|
Nur MM
|
2009
|
Glucose metabolism in overweight Hispanic adolescents with and without polycystic ovary syndrome.
|
19708174
|
Begum MR
|
2009
|
Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome.
|
19711741
|
Meczekalski B
|
2009
|
[The role of inhibins in functions and dysfunctions of female reproduction--Part II].
|
19713424
|
Tosi F
|
2009
|
Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome.
|
19714502
|
Crisosto N
|
2009
|
Testosterone-induced downregulation of anti-M?llerian hormone expression in granulosa cells from small bovine follicles.
|
19718565
|
Liu X
|
2010
|
Genetic variants of cyclin-dependent kinase 5 regulatory subunit associated protein 1-like 1 and transcription factor 7-like 2 are not associated with polycystic ovary syndrome in Chinese women.
|
19718569
|
Cetinkalp S
|
2010
|
The relationship of the Fas 670 A/G gene polymorphism with cardiovascular risk factors in polycystic ovary syndrome (PCOS) patients.
|
19718570
|
Unluhizarci K
|
2010
|
The prevalence of non-classic adrenal hyperplasia among Turkish women with hyperandrogenism.
|
19718584
|
Alshammari A
|
2010
|
Does the presence of polycystic ovary syndrome increase the risk of obstetrical complications in women with gestational diabetes?
|
19720270
|
Benjamins LJ
|
2009
|
Evaluation and management of polycystic ovary syndrome.
|
19721481
|
Carlsen SM
|
2009
|
[Use of metformin in polycystic ovary syndrome].
|
19723303
|
Mohamed-Hussein ZA
|
2009
|
Construction of a polycystic ovarian syndrome (PCOS) pathway based on the interactions of PCOS-related proteins retrieved from bibliomic data.
|
19726039
|
Pall M
|
2010
|
The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
|
19729161
|
Ashrafinia M
|
2009
|
Comparison of metformin treatment and laparoscopic ovarian diathermy in patients with polycystic ovary syndrome.
|
19729414
|
Bausenwein J
|
2010
|
Elevated levels of oxidized low-density lipoprotein and of catalase activity in follicular fluid of obese women.
|
19729797
|
Samy N
|
2009
|
Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.
|
19732872
|
Farhi J
|
2010
|
Administration of clomiphene citrate in patients with polycystic ovary syndrome, without inducing withdrawal bleeding, achieves comparable treatment characteristics and outcome.
|
19732886
|
Gu BH
|
2009
|
Follicle-stimulating hormone receptor polymorphisms and polycystic ovary syndrome.
|
19732888
|
Abu Hashim H
|
2010
|
Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial.
|
19733099
|
Shah B
|
2010
|
Endometrial thickness, uterine, and ovarian ultrasonographic features in adolescents with polycystic ovarian syndrome.
|
19734445
|
Fauser BC
|
2009
|
Predicting pregnancy in women with polycystic ovary syndrome.
|
19735349
|
Jeanes YM
|
2009
|
Dietary management of women with polycystic ovary syndrome in the United Kingdom: the role of dietitians.
|
19740916
|
Gowri V
|
2009
|
Investigating infertility.
|
19744034
|
Erdogan M
|
2009
|
The relationship of the interleukin-6 -174 G>C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients.
|
19749195
|
James WH
|
2009
|
A new method for testing a hypothesis on a cause of polycystic ovary syndrome.
|
19749677
|
De Leo V
|
2009
|
[Low dose oral contraceptives: 30 microg are still used?].
|
19754381
|
Motta AB
|
2009
|
Mechanisms involved in metformin action in the treatment of polycystic ovary syndrome.
|
19757237
|
Duijkers IJ
|
2010
|
Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women.
|
19757275
|
Qublan HS
|
2009
|
Metformin in the treatment of clomiphene citrate-resistant women with polycystic ovary syndrome undergoing in vitro fertilisation treatment: a randomised controlled trial.
|
19761360
|
Overbeek A
|
2009
|
Pharmacogenomics of ovulation induction: facilitating decisions on who, when and how to treat.
|
19763092
|
Oh JY
|
2010
|
Optimal waist circumference for prediction of metabolic syndrome in young Korean women with polycystic ovary syndrome.
|
19765700
|
Rocha MP
|
2010
|
Metabolism of triglyceride-rich lipoproteins and lipid transfer to high-density lipoprotein in young obese and normal-weight patients with polycystic ovary syndrome.
|
19766209
|
Hu Z
|
2010
|
The role of family history in clinical symptoms and therapeutic outcomes of women with polycystic ovary syndrome.
|
19771438
|
Verit FF
|
2010
|
High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
|
19775306
|
Seneviratne HR
|
2009
|
Serum insulin patterns and the relationship between insulin sensitivity and glycaemic profile in women with polycystic ovary syndrome.
|
19778476
|
Dittrich R
|
2009
|
Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS.
|
19778486
|
Chittenden BG
|
2009
|
Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review.
|
19781047
|
Zhang HY
|
2009
|
Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population.
|
19781696
|
Harris-Glocker M
|
2010
|
Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin.
|
19782347
|
Verit FF
|
2009
|
Serologic markers of autoimmunity in women with the polycystic ovary syndrome.
|
19782351
|
Wang Y
|
2010
|
Different phenotypes of polycystic ovary syndrome by Rotterdam criteria are differently steroidogenic but similarly insulin resistant.
|
19782356
|
Kaya C
|
2010
|
Relationship between interleukin-6 levels and ambulatory blood pressure in women with polycystic ovary syndrome.
|
19782423
|
Kawai T
|
2009
|
Variation in the perilipin gene (PLIN) affects glucose and lipid metabolism in non-Hispanic white women with and without polycystic ovary syndrome.
|
19782978
|
Ozerkan K
|
2010
|
Insulin-like growth factor-1 and insulin-like growth factor-binding protein-1 in patients with polycystic ovary syndrome during clomiphene citrate therapy.
|
19794294
|
Meczekalski B
|
2009
|
Oocyte-specific genes: role in fertility and infertility.
|
19796964
|
de Zegher F
|
2009
|
Adipose tissue expandability and the early origins of PCOS.
|
19800728
|
Papaleo E
|
2009
|
Contribution of myo-inositol to reproduction.
|
19803824
|
Wiegratz I
|
2006
|
Extended and continuous use of hormonal contraceptives to reduce menstruation.
|
19803867
|
Lim SS
|
2007
|
Obesity management in women with polycystic ovary syndrome.
|
19803884
|
Unluhizarci K
|
2005
|
The evaluation and treatment of hirsute women.
|
19803963
|
Diamanti-Kandarakis E
|
2006
|
Update on polycystic ovary syndrome.
|
19803983
|
Szalat A
|
2007
|
Gender-specific care of diabetes.
|
19803994
|
Yasmin E
|
2007
|
Management of polycystic ovary syndrome.
|
19804008
|
Seng SW
|
2006
|
Gonadotropin-releasing hormone antagonist in in vitro fertilization superovulation.
|
19804310
|
Rizzo M
|
2007
|
Update on the role of the atherogenic lipoprotein phenotype in cardiovascular prevention.
|
19805079
|
Mutskov V
|
2009
|
The human insulin gene is part of a large open chromatin domain specific for human islets.
|
19808859
|
de Zegher F
|
2009
|
Early Origins of polycystic ovary syndrome: hypotheses may change without notice.
|
19809318
|
Palomba S
|
2009
|
Management strategies for ovulation induction in women with polycystic ovary syndrome and known clomifene citrate resistance.
|
19809879
|
Ode KL
|
2009
|
Identification and treatment of metabolic complications in pediatric obesity.
|
19811070
|
Atiomo WU
|
2009
|
Framework for a systems approach to proteomic biomarker profiling in polycystic ovary syndrome.
|
19811236
|
Carmina E
|
2009
|
Cardiovascular risk and events in polycystic ovary syndrome.
|
19815190
|
Gosman GG
|
2010
|
Reproductive health of women electing bariatric surgery.
|
19818376
|
Racho? D
|
2010
|
Ovarian function and obesity--interrelationship, impact on women's reproductive lifespan and treatment options.
|
19820292
|
Misiti S
|
2010
|
Proteomic profiles in hyperandrogenic syndromes.
|
19820295
|
Selimoglu H
|
2010
|
The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome.
|
19821101
|
Chu Y
|
2009
|
The expression of resistin in adipose tissues of patients with polycystic ovary syndrome and insulin resistance.
|
19821295
|
Brown J
|
2009
|
Clomiphene and anti-oestrogens for ovulation induction in PCOS.
|
19821299
|
Tang T
|
2009
|
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
|
19827418
|
Klein F
|
2009
|
[Polycystic ovary syndrome. Diet helps control hormone chaos].
|
19827632
|
Reznikov OH
|
2009
|
[Enhancing effect of androgen receptor antagonist on gonadotropic inductors of ovulation in rats with polycystic ovaries].
|
19828691
|
Zhu JQ
|
2010
|
Demethylation of LHR in dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome.
|
19832825
|
Dewailly D
|
2010
|
Metabolic syndrome in young women with the polycystic ovary syndrome: revisiting the threshold for an abnormally decreased high-density lipoprotein cholesterol serum level.
|
19832931
|
Caruso S
|
2009
|
Quality of sexual life in hyperandrogenic women treated with an oral contraceptive containing chlormadinone acetate.
|
19834313
|
Moran LJ
|
2010
|
Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention.
|
19835809
|
Fambrini M
|
2009
|
Levonorgestrel-releasing intrauterine system alone as primary treatment in young women with early endometrial cancer: case report.
|
19837913
|
Coviello AD
|
2009
|
High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity.
|
19837928
|
Jones MR
|
2009
|
Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6 17beta-hydroxysteroid dehydrogenase gene.
|
19838579
|
Fernandes JB
|
2009
|
[Obesity and altered arterial structure in young women with micropolycystic ovary syndrome].
|
19841045
|
Diamanti-Kandarakis E
|
2010
|
Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome.
|
19843067
|
Nakhjavani M
|
2009
|
Short term effects of spironolactone on blood lipid profile: a 3-month study on a cohort of young women with hirsutism.
|
19843375
|
Oyawoye OA
|
2009
|
The interaction between follicular fluid total antioxidant capacity, infertility and early reproductive outcomes during in vitro fertilization.
|
19844814
|
Wang J
|
2009
|
FABP4: a novel candidate gene for polycystic ovary syndrome.
|
19845194
|
Awonuga AO
|
2009
|
Non-adherence to instructions to cancel a cycle in a patient overstimulated with gonadotropins in a planned intrauterine insemination cycle.
|
19845195
|
Chervenak FA
|
2009
|
Preventive ethics and subsequent care of patients self-administering ovarian stimulation for the management of infertility.
|
19846740
|
Alsamarai S
|
2009
|
Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age.
|
19848208
|
Li Q
|
2009
|
[Effect of bushen tongmai recipe on insulin resistance and ovulation dysfunction in PCOS rats accompanied with insulin resistance].
|
19850592
|
Rosencrantz MA
|
2010
|
Comparison of inhibin B and estradiol responses to intravenous FSH in women with polycystic ovary syndrome and normal women.
|
19852285
|
Yu J
|
2009
|
[Fifty years of experience on integrative medical treatment of polycystic ovarian syndrome].
|
19852286
|
Huang HF
|
2009
|
[Genetic mechanism of polycystic ovarian syndrome].
|
19852287
|
Wu XK
|
2009
|
[Exploration into the pathogenesis and treatment of polycystic ovarian syndrome from viewpoints of menstrual disorder and phlegm accumulation in uterus].
|
19852289
|
Zhao H
|
2009
|
[Advantages of Chinese medicine for treatment of blood sugar and lipid metabolic disorders in patients with polycystic ovarian syndrome].
|
19852296
|
Gao L
|
2009
|
[Of berberine and puerarin on dexamethasone-induced insulin resistance in porcine ovarian thecal cells].
|
19855107
|
Lujan ME
|
2010
|
Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome.
|
19856137
|
Lin S
|
2009
|
The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.
|
19859840
|
Yan Q
|
2009
|
Association of the common rs9939609 variant of FTO gene with polycystic ovary syndrome in Chinese women.
|
19860350
|
Check JH
|
2009
|
Failure to have menses following progesterone withdrawal in a normal estrogenic woman with polycystic ovarian syndrome who menstruates with oral contraceptives.
|
19874358
|
Ingram JR
|
2010
|
Management of acne vulgaris: an evidence-based update.
|
19883437
|
Yamada S
|
2009
|
Stromal luteoma and nodular hyperthecosis of the bilateral ovaries associated with atypical endometrial hyperplasia of the uterus.
|
19883744
|
Manner?s L
|
2010
|
Beneficial metabolic effects of the Malaysian herb Labisia pumila var. alata in a rat model of polycystic ovary syndrome.
|